- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07270757
Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Atrial Fibrillation Patients
Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Patients With Atrial Fibrillation: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background The comprehensive management of atrial fibrillation (AF) has evolved from mere rhythm control to improving patients' symptoms, functional status, and long-term prognosis. While catheter ablation effectively restores sinus rhythm, a significant clinical paradox exists: many patients fail to achieve ideal recovery in objective cardiorespiratory function and subjective quality of life even after technically successful procedures. This gap between "technical success" and "functional recovery" reveals major deficiencies in the current fragmented, procedure-centric management model.
The core of this deficiency lies in the systematic neglect of patients' physiological and psychological reserves during the perioperative period. Studies show that up to 70% of AF patients experience kinesiophobia (fear of movement), which becomes exacerbated during the perioperative period and severely hinders patients' willingness and compliance to participate in rehabilitation. Meanwhile, the high incidence of atrial arrhythmic events during the three-month post-operative "blanking period" not only increases clinical management complexity but also indirectly affects patients' functional recovery through medication adjustments and activity restrictions. These factors together form a "physiological-psychological" vicious cycle that ultimately affects patients' long-term outcomes.
Study Objectives This study aims to evaluate whether a physician-supervised structured preoperative prehabilitation program can serve as an effective integrated strategy to simultaneously improve both hard clinical outcomes and objective functional indicators in AF ablation patients.
Specific objectives include:
To evaluate the improvement effect of prehabilitation on peak oxygen uptake at 3 months post-ablation To evaluate the preventive effect of prehabilitation on atrial arrhythmic events within 90 days post-ablation To evaluate the improvement effect of prehabilitation on patient-reported outcomes (including kinesiophobia, quality of life, etc.)
Study Design This is a prospective, single-center, assessor-blinded randomized controlled trial. We plan to enroll 100 eligible patients who will be randomly allocated in a 1:1 ratio to either the prehabilitation group or the usual care group.
Interventions
The prehabilitation group will receive a 4-week structured program before ablation, including:
Individualized exercise training: Prescription based on cardiopulmonary exercise test results, including aerobic exercise (40%-60% of heart rate reserve) and resistance training Psychological and educational intervention: Structured education based on cognitive behavioral therapy principles, focusing on addressing kinesiophobia The usual care group will receive only standard preoperative education without structured rehabilitation.
Assessment and Follow-up Main assessment timepoints include baseline, 3 months post-ablation, and 6 months post-ablation.
Primary endpoints: Peak oxygen uptake, incidence of atrial arrhythmic events Secondary endpoints: Other cardiorespiratory parameters, patient-reported outcomes, clinical events Safety indicators: Adverse events, program adherence Statistical Methods Intention-to-treat analysis will be applied. Continuous variables will be analyzed using ANCOVA, categorical variables using chi-square test, and time-to-event data using Kaplan-Meier survival analysis.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kexin Wang
- Phone Number: +8618018223427
- Email: 840507356@qq.com
Study Locations
-
-
Please Select
-
Nanjing, Please Select, China
- Recruiting
- The First Affiliated Hospital with Nanjing Medical University
-
Contact:
- Kexin Wang
- Phone Number: +8618018223427
- Email: 840507356@qq.com
-
Contact:
- Weizhu Ju
- Email: juweizhu@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18-70 years
- Scheduled for first AF ablation
- NYHA class I-II
- LVEF ≥ 50%
Exclusion Criteria:
- Significant structural heart disease (e.g., severe valvular disease)
- Contraindications to CPET or exercise training
- Cognitive impairment preventing cooperation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prehabilitation Group
Structured Prehabilitation Program for 4 weeks before ablation
|
The prehabilitation group will receive a 4-week structured program before ablation, including: Individualized exercise training: Prescription based on cardiopulmonary exercise test results, including aerobic exercise (40%-60% of heart rate reserve) and resistance training Psychological and educational intervention: Structured education based on cognitive behavioral therapy principles, focusing on addressing kinesiophobia Delivery mode: Hybrid (supervised in-hospital sessions + monitored home-based sessions) The usual care group will receive only standard preoperative education without structured rehabilitation. |
|
No Intervention: Usual Care Group
Standard Preoperative Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Oxygen Uptake at 3 months
Time Frame: 3 months post-ablation
|
Measure: Cardiopulmonary exercise testing
|
3 months post-ablation
|
|
Atrial Arrhythmic Events within 90 days
Time Frame: Within 90 days post-ablation
|
Any atrial arrhythmic events happened within 90 days after the procedure
|
Within 90 days post-ablation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-SR-429
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation (AF)
-
Abbott Medical DevicesRecruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Paroxysmal AFSpain, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Lithuania, Poland
-
Arga Medtech SARecruitingAtrial Fibrillation (AF) | Paroxysmal AF | Persistant Atrial FibrillationUnited States, Netherlands, Croatia, Belgium, Lithuania, Czechia
-
Boston Scientific CorporationRecruitingLeft Atrial Appendage Closure | Non-valvular Atrial Fibrillation (AF)Spain, Germany, Denmark, Switzerland, Italy
-
Boston Scientific CorporationCompleted
-
Boston Scientific CorporationRecruitingAtrial Fibrillation (AF) | Persistant Atrial FibrillationUnited States, Spain, Belgium, France, Netherlands, Germany, Hong Kong
-
Medtronic Cardiac Ablation SolutionsRecruitingParoxysmal Atrial Fibrillation (PAF) | Persistent Atrial Fibrillation | Atrial Fibrillation (AF)Australia, United States, France, Belgium, Switzerland, Czechia
-
Navy General Hospital, BeijingNot yet recruitingAtrial Fibrillation (AF) | Atrial Fibrillation Burden
-
Gødstrup HospitalUniversity of AarhusNot yet recruitingAtrial Flutter | Atrial Fibrillation (AF)Denmark
-
Vital Audio IncMinneapolis Heart Institute FoundationNot yet recruitingAtrial Flutter | Atrial Fibrillation (AF)
-
VZW Cardiovascular Research Center AalstBiosense Webster, Inc.RecruitingAtrial Fibrillation (AF) | Paroxysmal AFBelgium
Clinical Trials on 4-week structured prehabilitation program (exercise training + psychological education)
-
University of CalgaryCanadian Institutes of Health Research (CIHR)Completed
-
The First Hospital of Hebei Medical UniversityCompletedCoronary Artery DiseaseChina
-
Universidad de La FronteraRecruitingPrehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy (NEO STRONG)Breast Cancer | Resistance Training | Postmenopause | PrehabilitationChile
-
Okan UniversityHealth Sciences University Istanbul Haydarpaşa Numune Training and Research...Not yet recruitingBariatric Surgery | Obesity (BMI > 35)
-
Democritus University of ThraceUniversity of Crete (School of Medicine); University Hospital of Heraklion...CompletedChronic Non-specific Neck Pain | Chronic Non-specific Low-Back PainGreece
-
Universiti Sains MalaysiaActive, not recruitingLower Crossed SyndromeChina
-
University of PadovaCompleted
-
Karadeniz Technical UniversityCompletedEarly Childhood Caries (ECC)Turkey (Türkiye)
-
Oslo University HospitalUnknownHip OsteoarthritisNorway
-
Ullevaal University HospitalUnknownExercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. Long-term Follow-up.Hip OsteoarthritisNorway